110 related articles for article (PubMed ID: 24878819)
1. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract][Full Text] [Related]
2. Involvement of nuclear NHERF1 in colorectal cancer progression.
Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
[TBL] [Abstract][Full Text] [Related]
3. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
4. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
5. Biological role of NHERF1 protein expression in breast cancer.
Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
7. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
Bellizzi A; Mangia A; Malfettone A; Cardone RA; Simone G; Reshkin SJ; Paradiso A
Histopathology; 2011 Jun; 58(7):1086-95. PubMed ID: 21707710
[TBL] [Abstract][Full Text] [Related]
8. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
[TBL] [Abstract][Full Text] [Related]
9. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
[TBL] [Abstract][Full Text] [Related]
11. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
12. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
13. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.
Bellizzi A; Greco MR; Rubino R; Paradiso A; Forciniti S; Zeeberg K; Cardone RA; Reshkin SJ
Int J Oncol; 2015 Mar; 46(3):1214-24. PubMed ID: 25530180
[TBL] [Abstract][Full Text] [Related]
14. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
15. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
[TBL] [Abstract][Full Text] [Related]
16. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
17. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
[TBL] [Abstract][Full Text] [Related]
19. Role of Na+/H+ exchanger regulatory factor 1 in forward trafficking of the type IIa Na+-Pi cotransporter.
Ketchem CJ; Khundmiri SJ; Gaweda AE; Murray R; Clark BJ; Weinman EJ; Lederer ED
Am J Physiol Renal Physiol; 2015 Jul; 309(2):F109-19. PubMed ID: 25995109
[TBL] [Abstract][Full Text] [Related]
20. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
Wang JQ; Qin F; Zhu L
J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]